125
Participants
Start Date
June 29, 2020
Primary Completion Date
February 15, 2024
Study Completion Date
May 30, 2024
LAU-7b
LAU-7b will be administered orally once-a-day with the main meal of the day, if possible, for a total of up to 14 days.
Placebo oral capsule
Placebo will be administered orally once-a-day with the main meal of the day, if possible, for a total of up to 14 days.
Staten Island University Hospital North, Staten Island
Robert Packer Hospital, Sayre
MedStar Washington Hospital Center, Washington D.C.
Anne Arundel Medical Center, 2001 Medical Parkway, Belcher Pavillion, Annapolis
Wake Forest University Health Science, Winston-Salem
Baptist Medical Center Beaches, Jacksonville Beach
OhioHealth Riverside Methodist Hospital, Columbus
Kettering Health, Kettering
Wayne State University, Harper University Hospital and Detroit Receiving Hospital, Detroit
Henry Ford Health System, Detroit
University of Iowa Hospitals and Clinics, Iowa City
NorthShore University Health System - Glenbrook Hospital, Glenview
NorthShore University Health System - Swedish Hospital, Chicago
PRX Research /Dallas Regional Medical Center, Mesquite
University of Texas Southwestern, Dallas
Houston Methodist Hospital, Houston
St Lukes Hospital, Boise
University of Utah Health, Salt Lake City
Chandler Regional Medical Center / Mercy Gilbert Medical Center, Chandler
University Medical Center of Southern Nevada, Las Vegas
Hoag Memorial Hospital Presbyterian, Newport Beach
University of California Davis Medical Center, Sacramento
Nuvance Health - Danbury Hospital, Danbury
Centre d'études cliniques CIUSS SLJ, Hôpital Chicoutimi, Chicoutimi
CIUSSSS de l'Est-de-l'Ile-de-Montréal, Hôpital Maisonneuve-Rosemont, Montreal
Centre Hospitalier de l'Université de Montréal, Montreal
Jewish General Hospital, Montreal
McGill University Health Centre, Montreal
CISSS Des Laurentides, Saint-Jérôme
Lead Sponsor
Laurent Pharmaceuticals Inc.
INDUSTRY